| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 354 |
| 1 | INJECTION SITE PAIN | 160 |
| 2 | INJECTION SITE HAEMORRHAGE | 142 |
| 3 | DRUG INEFFECTIVE | 111 |
| 4 | OFF LABEL USE | 100 |
| 5 | INJECTION SITE MASS | 61 |
| 6 | FATIGUE | 57 |
| 7 | INJECTION SITE BRUISING | 56 |
| 8 | ACCIDENTAL EXPOSURE TO PRODUCT | 53 |
| 9 | PRODUCT DOSE OMISSION | 52 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | CARDIAC VALVE FIBROELASTOMA | 4 | 0.1026 |
| 1 | GLUCOSE TOLERANCE DECREASED | 4 | 0.0976 |
| 2 | PERFORMANCE ENHANCING PRODUCT USE | 5 | 0.0505 |
| 3 | FORCED EXPIRATORY VOLUME ABNORMAL | 6 | 0.0414 |
| 4 | PUNCTURE SITE REACTION | 3 | 0.0375 |
| 5 | BILE DUCT ADENOCARCINOMA | 2 | 0.0333 |
| 6 | SECONDARY HYPOGONADISM | 9 | 0.0273 |
| 7 | FRACTIONAL EXHALED NITRIC OXIDE INCREASED | 4 | 0.0223 |
| 8 | BLOOD FOLLICLE STIMULATING HORMONE DECREASED | 3 | 0.0170 |
| 9 | BLOOD LUTEINISING HORMONE DECREASED | 3 | 0.0168 |